[
    [
        {
            "time": "2021-08-31",
            "original_text": "国金证券维持华兰生物买入评级：血制品和疫苗业务下半年有望改善和放量",
            "features": {
                "keywords": [
                    "华兰生物",
                    "血制品",
                    "疫苗",
                    "下半年",
                    "改善",
                    "放量"
                ],
                "sentiment_score": 0.75,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "国金证券维持华兰生物买入评级：血制品和疫苗业务下半年有望改善和放量",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 5,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-08-31",
            "original_text": "5000亿“光伏茅”又飙新高！高瓴8个月赚150亿",
            "features": {
                "keywords": [
                    "光伏",
                    "高瓴",
                    "新高",
                    "8个月",
                    "150亿"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "新能源"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "5000亿“光伏茅”又飙新高！高瓴8个月赚150亿",
                "Correlation": 5,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 8,
                "Duration": 6,
                "Entity_Density": 4,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-08-31",
            "original_text": "华兰生物董事长增持自家股 不排除未来继续增持",
            "features": {
                "keywords": [
                    "华兰生物",
                    "董事长",
                    "增持",
                    "未来",
                    "继续"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "华兰生物董事长增持自家股 不排除未来继续增持",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 3,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        }
    ]
]